Home>APIs>

Enalapril Maleate

CAS number: 76095-16-4

Molecular formula: C24H32N2O9

molecular weight: 492.52

Chemical structure:

Producers shown on SFDA

(Record date:02/09/2021)

Producer

Documents

GMP Valid till(based on SFDA)

Zhejiang Changming Pharmaceutical Co., Ltd.

GMP, DMF
Valid till February 2024

Zhejiang Huahai Pharmaceutical Co., Ltd.

GMP, DMF
Valid till October 2021

Shanghai Xiandai Hasen(Shangqiu) Pharmaceutical Co., Ltd.

GMP
Valid till January 2019


Producers shown on EP

(Quoted from EP website;record date:02/09/2021)

Substance
Certificate Holder
Certificate Number
Issue Date
Status
End date
Type
Enalapril maleate
Wockhardt Limited IN 393 002 Ankleshwar
  R0-CEP 2001-062-Rev 00
17/01/2005
EXPIRED
17/01/2010
Chemistry
Enalapril maleate
DR. REDDY'S LABORATORIES LIMITED IN 500 034 Hyderabad
  R1-CEP 2002-076-Rev 05
28/08/2018
VALID
/Chemistry
Enalapril maleate
Ranbaxy Laboratories Limited IN 122 015 Gurgaon
  R1-CEP 2000-084-Rev 01
14/03/2008
WITHDRAWN BY HOLDER
23/07/2010
Chemistry
Enalapril maleate
EXCELLA GMBH DE 90537 Feucht
  R0-CEP 2002-179-Rev 01
13/06/2008
EXPIRED
28/01/2010
Chemistry
Enalapril maleate
ESTEVE QUIMICA S.A. ES 08038 Barcelona
  R1-CEP 2000-258-Rev 04
28/10/2020
VALID
/Chemistry
Enalapril maleate
GEDEON RICHTER PLC HU 1103 Budapest
  R1-CEP 2001-408-Rev 03
25/11/2010
WITHDRAWN BY HOLDER
31/07/2013
Chemistry
Enalapril maleate
GULF OIL Corporation Limited IN 500 018 Hyderabad
  R0-CEP 2005-206-Rev 00
01/08/2007
WITHDRAWN BY EDQM
13/10/2010
Chemistry
Enalapril maleate
Farmhispania, S.A. ES 08160 Montmeló
  R1-CEP 2006-104-Rev 01
14/03/2013
VALID
/Chemistry
Enalapril maleate
ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai
  R1-CEP 2009-367-Rev 01
27/05/2016
VALID
/Chemistry
Enalapril maleate
KRKA d.d. SI 8501 Novo Mesto
  R1-CEP 2000-212-Rev 02
10/09/2010
VALID
/Chemistry
Enalapril maleate
Inke, S.A. ES 08755 Castellbisbal
  R1-CEP 2000-070-Rev 04
21/02/2019
VALID
/Chemistry
Enalapril maleate
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. CN 317 024 Linhai
  R1-CEP 2000-053-Rev 05
17/12/2019
VALID
/Chemistry
Enalapril maleate
SRI KRISHNA PHARMACEUTICALS LIMITED IN 500 039 Hyderabad
  R1-CEP 2001-308-Rev 05
02/10/2020
VALID
/Chemistry
Enalapril maleate
Neuland Laboratories Limited IN 500 034 Hyderabad
  R1-CEP 2003-078-Rev 11
04/09/2020
VALID
/Chemistry


Producer:Zhejiang Changming Pharmaceutical Co., Ltd. has a registered capital of 50 million yuan, covers an area of more than 90 Mu and employs more than 250 people,

It has a modern workshop in line with GMP standards, and has passed the new domestic GMP certification, FDA review, EU official review, ISO9001 quality management system certification, ISO14001 environmental management system certification and OHSAS18000 occupational health and safety management system certification.

Staff size:200-299 persons

Registered capital:RMB 50 million


Producer:Zhejiang Huahai Pharmaceutical Co., Ltd.was founded in 1989 and headquartered in Zhejiang, China. The company has nearly 7000 employees and more than 40 subsidiaries around the world (including China, the United States, Japan, Germany, etc.As a leading enterprise in the internationalization of Chinese medicine, Huahai pharmaceutical is the first pharmaceutical company in China to pass the FDA preparation quality certification and independently own the Anda document number. It is also the first Chinese pharmaceutical company to realize large-scale preparation sales in the United States. It has established China's pharmaceutical quality image in the world's high-end pharmaceutical market.

Staff size:About 7000 persons

Registered capital:RMB 1 billion 492 million


Producer:Shanghai Xiandai Hasen(Shangqiu) Pharmaceutical Co., Ltd.is a holding company invested and established by the listed company Shanghai Hyundai Pharmaceutical Co., Ltd. (stock code 600420). The major shareholder is China Pharmaceutical Group Corporation. It is a pharmaceutical enterprise built in strict accordance with the modern enterprise system and the requirements of national GMP. It is a diversified enterprise integrating drug R & D, production and sales Modern national essential drug production base. The company covers an area of more than 500 mu, has a registered capital of 83.29 million yuan, a total asset of more than 600 million yuan, and has more than 1600 employees, including more than 800 professional and technical personnel; The company has obtained 163 drug production approval products, and has GMP production lines for small volume injections, oral solid preparations (tablets, capsules, granules), APIs and other dosage forms. The annual production capacity of small volume injections is 4 billion tubes, 6 billion tablets (granules and bags) of oral solid preparations and 1200 tons of API.

Staff size:1000-1999 persons

Registered capital:RMB 83.29 million


For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978